Evidence map›Paper›PMID 25889509›Full record

Trial reportRespiratory research2015

A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.

Patricia A Cassano, Kristin A Guertin, Alan R Kristal, Kathryn E Ritchie, Monica L Bertoia, Kathryn B Arnold, John J Crowley, JoAnn Hartline, Phyllis J Goodman, Catherine M Tangen and 3 more

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Respiratory research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00241865, which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00241865 no registry record found
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Patricia A CassanoDivision of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY, 14853, USA. pac6@cornell.edu.
Kristin A GuertinDivision of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY, 14853, USA. kam84@cornell.edu.
Alan R KristalDepartment of Epidemiology, University of Washington, Seattle, WA, USA. Alan.Kristal@fhcrc.org.
Kathryn E RitchieDivision of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY, 14853, USA. ker32@cornell.edu.
Monica L BertoiaDivision of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY, 14853, USA. monica.bertoia@gmail.com.
Kathryn B ArnoldSWOG Statistical Center, Seattle, WA, USA. karnold@fhcrc.org.
John J CrowleySWOG Statistical Center, Seattle, WA, USA. johnc@crab.org.
JoAnn HartlineSWOG Statistical Center, Seattle, WA, USA. joannh@crab.org.
Phyllis J GoodmanSWOG Statistical Center, Seattle, WA, USA. pgoodman@fhcrc.org.
Catherine M TangenFred Hutchinson Cancer Research Center, Seattle, WA, USA. ctangen@fhcrc.org.
Lori M MinasianDivision of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. minasilo@mail.nih.gov.
Scott M LippmanUniversity of California San Diego, Moores Cancer Center, La Jolla, CA, USA. slippman@ucsd.edu.
Eric KleinCleveland Clinic, Cleveland, OH, USA. Kleine@ccf.org.
Cancer Research And Biostatistics · USCornell University · USCleveland Clinic · USFred Hutch Cancer Center · USNational Cancer Institute · USUniversity of California, San Diego · USUniversity of Washington · US

Funding

SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research UM1CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2013 to 2017
$5.2M
Supplemental Se and Vitamin E and Pulmonary FunctionR01HL071022 · NHLBI · CORNELL UNIVERSITY ITHACA · PI CASSANO, PATRICIA A · 2003 to 2007
$3.1M
NCI NIH HHS 5UM1CA182883NCI NIH HHS CA37429NCI NIH HHS U10 CA037429NCI NIH HHS UG1 CA189974NCI NIH HHS UM1 CA182883NHLBI NIH HHS R01 HL071022NHLBI NIH HHS R01HL071022
6 · The paper itself

Abstract

backgroundThe intake of nutrients with antioxidant properties is hypothesized to augment antioxidant defenses, decrease oxidant damage to tissues, and attenuate age-related rate of decline in lung function. The objective was to determine whether long-term intervention with selenium and/or vitamin E supplements attenuates the annual rate of decline in lung function, particularly in cigarette smokers.

methodsThe Respiratory Ancillary Study (RAS) tested the single and joint effects of selenium (200 μg/d L-selenomethionine) and vitamin E (400 IU/day all rac-α-tocopheryl acetate) in a randomized double-blind placebo-controlled trial. At the end of the intervention, 1,641 men had repeated pulmonary function tests separated by an average of 3 years. Linear mixed-effects regression models estimated the effect of intervention on annual rate of decline in lung function.

resultsCompared to placebo, intervention had no main effect on either forced expiratory volume in the first second (FEV1) or forced expiratory flow (FEF25-75). There was no evidence for a smoking by treatment interaction for FEV1, but selenium attenuated rate of decline in FEF25-75 in current smokers (P = 0.0219). For current smokers randomized to selenium, annual rate of decline in FEF25-75 was similar to the annual decline experienced by never smokers randomized to placebo, with consistent effects for selenium alone and combined with vitamin E.

conclusionsAmong all men, there was no effect of selenium and/or vitamin E supplementation on rate of lung function decline. However, current smokers randomized to selenium had an attenuated rate of decline in FEF25-75, a marker of airflow.

trial registrationClinicaltrials.gov identifier: NCT00241865 .

Indexed as

AgedAntioxidantsDietary SupplementsDouble-Blind MethodDrug Therapy, CombinationFollow-Up StudiesHumansLungMaleMiddle AgedRespiratory Function TestsSeleniumSmokingVitamin EAntioxidantsSeleniumVitamin E

Identifiers

PMID25889509
PMCPMC4404242
OpenAlexW2134151713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.